A clinical evaluation committee assessment of recombinant human tissue factor pathway inhibitor (tifacogin) in patients with severe community-acquired pneumonia
暂无分享,去创建一个
R. Wunderink | S. Opal | E. Abraham | P. Laterre | L. Poole | A. Creasey | S. LaRosa | F. Xie